Videos

Christopher D’Avella, MD, talks about his institution’s use of the Flatiron Assist pathways program, and how the improvements made to the tool as a result of provider feedback increased the efficiency and utilization of the program.

Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”

Scott Swain, PhD, discusses his study on comparison of diversity across real-world evidence with clinical trial and SEER data in patients with metastatic breast cancer.

Smita Agrawal, PhD, executive director at ConcertAI, spoke about her study on deriving lines of therapy by integrating data from multiple data sources to improve accuracy.

Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.

In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...

Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.

Manali Kamdar, MD, University of Colorado Cancer Center, discusses the latest therapeutic options available for patients with primary refractory/early relapse diffuse large B-cell lymphoma.